Hôtel-Dieu de Québec
11 Côte du Palais, bureau 5212
Québec, Québec
Canada G1R 2J6
Dernières nouvelles
Information non disponible
Comparison of four-year toxicities and local control of ultra-hypofractionated vs moderate-hypofractionated image guided prostate radiation with HDR brachytherapy boost: A phase I-II single institution trial
Article de revueClin Transl Radiat Oncol, 40 , 2023.
Inter-observer evaluation of a GPU-based multicriteria optimization algorithm combined with plan navigation tools for HDR brachytherapy
Article de revueBrachytherapy, 21 (4), 2022.
Advantages of TRUS-based delineation for high-dose-rate prostate brachytherapy planning
Article de revueJ Contemp Brachytherapy, 14 (1), 2022.
Low Serum Testosterone in Men with Newly Diagnosed Androgen-Deprivation Therapy-Naïve Prostate Cancer and Its Relationship to Cardiovascular Risk Factors: A RADICAL-PC Substudy
Article de revueJ Urol, 207 (5), 2022.
PSA outcomes and late toxicity of single-fraction HDR brachytherapy and LDR brachytherapy as monotherapy in localized prostate cancer: A phase 2 randomized pilot study
Article de revueBrachytherapy, 20 (6), 2021.
Commissioning of an intra-operative US guided prostate HDR system integrating an EM tracking technology
Article de revueBrachytherapy, 20 (6), 2021.